Possemato A (2010) CST Curation Set: 9355; Year: 2010; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: smK

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

K180-sm - LECT1 (human) ▲
Modsite: VAVDQPVkDNSFLSS SwissProt Entrez-Gene Orthologous residues LECT1 (human): K180‑sm, LECT1 (mouse): K180‑sm, LECT1 (rat): K180‑sm Characterization Methods used to characterize site in vivo:  mass spectrometry Relevant cell lines - cell types - tissues:  Jurkat (T lymphocyte) Cellular systems studied:  cell lines Species studied:  human

K499-sm - MBD1 (human) ▲

Modsite: VVALPQVkQEkADtQ SwissProt Entrez-Gene Orthologous residues MBD1 (human): K499‑sm, MBD1 iso2 (human): ‑, MBD1 iso4 (human): ‑, MBD1 iso5 (human): K450‑sm, MBD1 iso9 (human): K524‑sm, MBD1 iso10 (human): K449‑sm, MBD1 iso11 (human): ‑, MBD1 iso12 (human): K499‑sm, MBD1 (mouse): K520‑sm, MBD1 (rat): K416‑sm Characterization Methods used to characterize site in vivo:  mass spectrometry Relevant cell lines - cell types - tissues:  Jurkat (T lymphocyte) Cellular systems studied:  cell lines Species studied:  human

K793-sm - TIF1G (human) ▲

Modsite: CsFsGGVkQEKTEDG SwissProt Entrez-Gene Orthologous residues TIF1G (human): K793‑sm, TIF1G iso2 (human): K793‑sm, TIF1G (mouse): K808‑sm, TIF1G iso2 (mouse): K808‑sm, TIF1G (rat): K714‑sm Characterization Methods used to characterize site in vivo:  mass spectrometry Relevant cell lines - cell types - tissues:  Jurkat (T lymphocyte) Cellular systems studied:  cell lines Species studied:  human